REPELLENT PATCH OF INSECTS BACKGROUND OF THE INVENTION 1. Technical Field This invention relates in general to an insect repellent patch and more particularly to a transdermal delivery system that delivers insect repellent to a user. 2. Previous Technology The need for an insect repellent is constant, particularly for those who are outdoors, climbing, camping or other recreational or work activity. One of the most common insects that are the target to be stopped by the insect repellent are mosquitoes. Mosquitoes need to be repelled not only because of the discomfort they cause from their bites, but more importantly due to vector-borne disease that can be transmitted from person to person as a result, most notably malaria and West Nile Virus. The conventional insect repellent comes in the form of spray, liquid and cream that is applied to the exposed skin to protect the exposed skin of insects and therefore insect bites. The average protection time varies in length and must be applied again after effectiveness falls. In addition, these conventional methods do not protect areas of the skin that are discovered later, such as when removing the sack. Other conventional insect repellents include patches infused with citronella oil. The essence repels insects and the patch can be applied on clothes, chairs, tents, beach towels, picnic tables, baby strollers, etc. While patches are easily applied and used, they are limited in their effectiveness by relying on essence to protect a person from insect stings. In particular, conventional insect repellents use N, N-diethyl-m-toluamide, commonly referred to as DEET. DEET is absorbed through the skin and passes into the blood. In cases where DEET is applied topically, up to 50% penetrates into human skin, and 17% is absorbed into the bloodstream. Blood concentrations of about 3 milligrams per liter have been reported several hours after the repellent was applied to the skin in a prescribed manner. In addition, DEET is also absorbed by the intestines. The DEET is of particular concern with the central nervous system. The laboratory animals that were exposed to the equivalent of the average human doses of DEET performed poorly in neuro-behavioral tasks requiring muscle coordination unlike the untreated animals. In addition, the combined exposure of DEET and permethrin, another ingredient in mosquito spray, can lead to motor deficits and learning and memory dysfunction. DEET can also have a significantly higher toxicity when combined with ethyl and isopropyl and Freon alcohols, which are components of some DEET repellents. DEET-containing products are required to carry instructions informing the user of the following: 1. It should not be used at all in children under 6 months of age; 2. Children from 6 months to 2 years of age can only use DEET once a day and in amounts less than 10%; and 3. Children ages 2 years to 12 years, can only use concentrations of 10%, and no more than 3 times a day. It is also required that products containing DEET carry labels that specify what should not be done, including: 1. Do not apply on cuts, wounds or irritated skin; Do not apply on hands or near the eyes and mouth of young children; do not let young children apply the product after returning to the interior, wash the skin treated with soap and water; and 3. Do not use under clothing; Do not spray in closed areas. It is also suggested that it is better to apply DEET to clothing to reduce exposure to DEET. In general, DEET is a repellent that causes substantial medical concerns. Correspondingly, what is needed is a long-lasting insect repellent patch and it is sure to be easy to apply as a patch and to protect all the skin, whether exposed or not, to insect bites. DISCLOSURE OF THE INVENTION The present invention relates to an insect repellent patch that is applied to a person's skin and provides constant protection for a prolonged period of time. One aspect of the present invention includes an insect repellent patch comprising a film saturated with vitamin Bl, wherein the amount of vitamin Bl in the film comprises a range of 50 milligrams to 100 milligrams and an adhesive coupled to one side of the film. The film is a patch with a transdermal delivery system comprising a backing to protect vitamin Bl from the environment, a container for retaining vitamin Bl and a membrane to control the release of vitamin Bl. The adhesive is configured to attach the film to a person's skin at a place on the skin without hair. In use, vitamin Bl is transferred from the patch to the person through absorbing it through the skin of the person in the person's bloodstream. The present invention further comprises an effective life of about 36 hours and the preferred range of vitamin Bl per patch is 65 to 85 milligrams with a specific amount of vitamin Bl preference of 75 milligrams. According to the particular aspects of the present invention, the film has a substantially square shape with dimensions of approximately 1.75 inches by 1.75 inches. Another aspect of the present invention includes an insect repellent patch comprising a film saturated with vitamin Bl, wherein the amount of vitamin Bl in the film comprises a range of 50 milligrams to 100 milligrams, an adhesive coupled to one side of the film and an effective life of approximately 36 hours. The invention further comprises a paper liner coupled to the adhesive to preserve the effectiveness of the adhesive until its actual use. The film is a transdermal delivery system patch comprising a backing to protect vitamin Bl from the environment, a container for retaining vitamin Bl and a membrane to control the release of vitamin Bl. The adhesive is configured to attach the film to the skin of the person in a place on the skin without hair. The film has a substantially square shape with dimensions of approximately 1.75 inches by 1.75 inches. Yet another aspect of the present invention includes a set of insect repellent patches comprising at least two films, each saturated with vitamin Bl, where the amount of vitamin Bl in the film comprises a range of 50 to 100 milligrams, an adhesive coupled to one side of each of the films, a silicone-coated paper liner coupled to the adhesive of at least two films to preserve the effectiveness of the adhesive until its actual use and an effective life of each of the films of approximately 36 hours. The adhesive attached to each of the films is configured to attach the film to a person's skin at a site of the hairless skin. The amount of vitamin Bl in each of the films is 75 milligrams. Each of the films is substantially square in shape with dimensions of approximately 1.75 inches by 1.75 inches. In particular embodiments, the paper liner is perforated so that a single patch is removed from the kit for use and the paper liner remains in place in each of at least two films. In addition, the patch set according to the embodiments comprises an outer cover that can be folded having an open position that provides access to at least two films and a closed position to retain at least two films, where the outer cover Folds in half and is partially secured when in closed position, thus folding the paper liner and placing the outer surfaces of at least two films against each other. The foregoing and other features and advantages of the present invention will be apparent from the following more detailed description of the particular embodiments of the invention, as illustrated in the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a front view of an insect repellent patch according to a particular embodiment of the present invention. Figure 2 is a sectional view of the insect repellent patch of Figure 1, taken along line 2-2.
Figure 3 is a front view of an insect repellent patch set according to a particular embodiment of the present invention; and Figure 4 is a perspective view of the insect repellent patch applied on an arm of a person. DETAILED DESCRIPTION OF THE FORMS OF REALIZATION OF THE
INVENTION As discussed above, the embodiments of the present invention relate to an insect repellent patch that is applied to a person's skin and provides constant protection for a prolonged period of time. Particular embodiments comprise a film saturated with Vitamin Bl and an adhesive. As shown in Figures 1 and 2, particular embodiments of the present invention may include an insect repellent patch 10. The patch 10 may be a transdermal delivery system patch, and in a particular embodiment , the patch 10 has a substantially square shape with dimensions of 1.75 inches by 1.75 inches. The patch comprises a backing 12, a container 14 of vitamin Bl, a membrane 16 and an adhesive 18. The backing 12 protects the container 14 of vitamin Bl in the container 14 from the environment. In particular, the back 12 prevents the evaporation of vitamin Bl, while remaining flexible and comfortable to be applied to a person's skin. It will be understood that in the particular embodiments of the invention, the backing 12 can be formed of polyethylene. However, it will be further understood by persons ordinarily qualified in the technology that the backing is not limited to being formed of polyethylene, but may also be formed of materials, such as the following, but not limited to, polyurethane and vinyl acetate. ethylene. The container 14 of the vitamin Bl is formed between the back 12 and the membrane 16 and is of sufficient size to retain an amount of vitamin VI that is within the range of 50-100 milligrams, with a preferred range of 65-85 milligrams. In the particular embodiments of the present invention, the container 14 is sufficient to retain 75 milligrams of vitamin Bl. The membrane 16 provides the other end of the container 14 so that it retains vitamin Bl within the container. The membrane also controls the release rate of vitamin Bl from container 14. Adhesive 18 is used to attach the patch to a person's skin. It will be understood by persons who are ordinarily qualified in the technology that the adhesive may be, of any type of adhesive that can perform the correct adhesion, such as, but not limited to, acrylate, silicone, polyisobutylene, and rubber-based adhesives. With reference to Figure 3, the present invention may include a set of insect repellent patches. The set 20 of patches may comprise at least two patches 20 insect repellents coupled to a liner 22. It should be understood that the liner 22 may be of a paper coated with silicone. The liner 22 protects the adhesive during storage and also prevents the release of vitamin Bl during the storage of the patch. In particular embodiments, the patch set 20 may comprise a perforation 24 separating at least the two patches 10. This allows the user to separate one patch 10 for use while retaining the other in storage. The game 20 of patches can be packaged and sold as individual games or as a group of games 20 of various patches. In use and according to Figure 4, a user 10 can apply a patch 10 to the skin 32. The skin 32 should preferably be clean, dry and hairless to provide the most resistant adhesion of the patch to the skin and to secure the skin. contact for vitamin Bl to be transferred from patch 10 to user 30. Patch 10 may include an amount of vitamin Bl within the range of 50-100 milligrams, with a preferred range of 65-85 milligrams. Vitamin Bl is transferred from patch 10 to user 30 through osmosis through and between the walls of squamous cells as they are present in the epidermis and dermis of human tissue. The vitamin Bl in the patch 10 enters the body and the normal diffusion provides protection against insects and any excess of vitamin Bl is safely excreted. It is also safe for infants as well as adults, and does not need dose concerns between ages and / or weights of users. A patch within the range of 50 - 100 milligrams can be used by users of all ages. In the particular embodiment of the present invention, the effective life of the insect repellent patch is up to 36 hours of continuous protection. In addition, the patch can be used for 24 hours in order to obtain full protection for 36 hours. Furthermore, the patch can be used for 2 hours before going outside, to maximize the benefit of the insect repellent patch by allowing time for the absorption of a portion of vitamin Bl in the body of the user, thus allowing the user between outside with the protection process indicated above. It should be understood by people ordinarily qualified in technology that this technology of transdermal delivery systems is a way of achieving the invention. The technology includes a flexible multi-layer polymer laminate system and a container system technology that stores and releases the active ingredients under a strict control rate that can provide a constant zero-order release over the life of the device. Life can be programmed to the range of one hour to several months. This technology eliminates any possibility of dose dumping. The transdermal delivery and delivery system provides an easy and highly efficient way to deliver the active ingredient and other compounds to the body through intact skin, thus offering many other advantages over traditional dosage forms. The embodiments and examples set forth herein were presented in order to explain in the best way the present invention and its practical application and to thus enable persons ordinarily trained in technology to recognize that the description and the previous examples have been presented for purposes of illustration and example only. The description as set forth is not intended to be exhaustive or to limit the invention to the precise form disclosed. Many modifications and variations are possible in light of the above teachings without departing spirit and scope of the claims below.